PharmaVentures InSights provides featured interviews and insight with industry leaders from the pharma, biotech and financial sectors. https://xitter.cf/t.co/73ZFHSlVm4
Oxford, England
Joined April 2008
- Tweets1.9K
- Following1.1K
- Followers11.5K
- Likes68
PharmaVentures is sorry to announce the passing of our Non-Executive Board Member Charles Macfarlane. He passed away last Saturday 15th June.
Charles was an exceptional man and truly unique. The combination of high intellect and wonderful charm made him…lnkd.in/dWtuJ9x
It’s been a privilege to have served as Board Member of this exciting NZ company. Within 9 months of joining the Board the company has been acquired by an Insight Ventures investment company Graphpad in the US. lnkd.in/gSEJasC
It has been a privilege to serve as a non-executive board member of this exciting NZ company. Within just 9 months of joining Biomatters the company was acquired. Innovation and entrepreneurialism is alive and kicking in New Zealand. lnkd.in/gRu68zv
Why should you make South Korea a deal making target? You are invited to watch our exclusive video discussion. LIVE today at 3pm BST and 6pm BST
For more details register here: bit.ly/2OhtBmV @PharmaVentures
Why you should make South Korea a deal making target? You are invited to watch our exclusive video discussion. August 1st 2018
For more details register here: bit.ly/2OhtBmV @PharmaVentures
Why should you make South Korea a deal making target? You are invited to watch our exclusive video discussion. August 1st 2018
For more details register here: bit.ly/2OhtBmV @PharmaVentures
Endomag raises $10 million USD (£8M GBP) to establish a new standard of breast cancer care @endomag endomagnetics.com/news/endom…
Knock your next deal out of the park. Meet with @PharmaVentures in Boston at the 2018 BIO International Convention - June 4th - 7th bit.ly/2IDUfTI
PharmaVentures retweeted
Another great addition for us at PharmaVentures!
PharmaVentures Strengthens its First Class Healthcare Strategy and Dealmaking Capabilities With the prn.to/2HAr7fR
PharmaVentures retweeted
PharmaVentures Strengthens Its First Class Strategy Consulting & Dealmaking Capabilities - mailchi.mp/pharmaventures.co…
Watch the final interview here bit.ly/2GeTLq1 xitter.cf/ImageBoxLSPR/status/93…
Great to arrange the interview for Stephane Boissel, @TxCellSA with @PharmaTV at @BiotechandMoney covering #celltherapy CAR-Tregs
Find out how the Sino-UK Fund is the bridge between the UK and China. @PharmaVentures @simonnhaworth Watch the FULL INTERVIEW here bit.ly/2FQYzBC
PREVIEW Interview with NetScientific: Fighting chronic diseases on three fronts @PharmaVentures FULL interview here - bit.ly/2tLAs1W
PREVIEW interview with BioSeed Capital: Aiming for new drugs, new deliveries and new cures @PharmaVentures FULL interview here - bit.ly/2ImsBL8
PharmaVentures retweeted
Are you Divesting or Acquiring at DCAT? - mailchi.mp/pharmaventures.co…
Watch:JJDC: Supporting the global entrepreneurial community bit.ly/2Fifd8X #PharmaTV Pharmaventures
Watch:NNRCO: Strategic alliance between Oxford University and Novo Nordisk bit.ly/2EYQDdp #PharmaTV Pharmaventures
